13F filer · CIK 902219 ↗
Wellington Management Group LLP
You are looking at Q1 2024. See the latest, Q2 2026 →
Reported value
$564.44B
+5.2% on the quarter before
Positions
1,887
205 new · 130 sold out
Top 10
21.4%
of the value
Est. gain
+$40.42B
on stocks held all quarter
Est. return
+8.4%
on those stocks since Q4 2023
Positions as of Mar 31, 2024, from Wellington Management Group LLP's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.
Portfolio at a glance
- New
- Added
- Cut
- Same
- Options
The 24 largest positions, 33% of the reported value, each sized by its share, colored by what the fund did with it since Q4 2023. Striped tiles are options.
Largest buys
Since Q4 2023, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Exxon Mobil Corp~$2.48BAdded · 0.1% → 0.6%+21,353,848 shares
- Wells Fargo Co New~$2.40BAdded · 0.2% → 0.6%+41,365,575 shares
- Nvidia~$2.03BAdded · 0.9% → 2.0%+2,243,054 shares
- Corpay Inc~$1.34BNew · 0.0% → 0.2%+4,347,524 shares
- American Express Co~$948.3MAdded · 0.6% → 0.9%+4,164,804 shares
- Amazon~$854.8MAdded · 2.2% → 2.6%+4,739,010 shares
- Nxp Semiconductors N V~$843.6MAdded · 0.3% → 0.4%+3,404,958 shares
- Eqt Corp~$769.2MAdded · 0.1% → 0.3%+20,749,989 shares
- Omnicom Group~$763.7MAdded · 0.1% → 0.2%+7,892,955 shares
- Everest Group Ltd~$741.2MAdded · 0.1% → 0.3%+1,864,613 shares
Largest sells
Since Q4 2023, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Pfizer Inc~$1.71BCut · 1.3% → 0.9%−61,512,148 shares
- Chubb Limited~$1.57BCut · 0.7% → 0.5%−6,068,139 shares
- Conocophillips~$1.49BCut · 0.9% → 0.6%−11,672,146 shares
- Microsoft~$1.37BCut · 4.4% → 4.4%−3,265,906 shares
- Fleetcor Technologies Inc~$1.32BSold out · 0.2% → 0.0%−4,683,613 shares
- AMD~$1.15BCut · 0.5% → 0.4%−6,351,479 shares
- Oracle~$993.9MCut · 0.2% → 0.0%−7,912,595 shares
- Intercontinental Exchange In~$954.9MCut · 0.4% → 0.2%−6,948,539 shares
- Diamondback Energy Inc~$903.9MCut · 0.4% → 0.3%−4,561,023 shares
- BlackRock~$869.8MCut · 0.3% → 0.1%−1,043,289 shares
Holdings
As of Mar 31, 2024. Changes are in shares against Dec 31, 2023, so a price move alone never reads as a buy or a sale.
| Holding | Value | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| MicrosoftCOM · shares −5.3% · price +11.9% | 4.4% | $24.74B | +$2.63B | ||||||||
| AmazonCOM · shares +6.1% · price +18.7% | 2.6% | $14.89B | +$2.21B | ||||||||
| Unitedhealth Group IncCOM · shares −0.4% · price −6.0% | 2.1% | $12.01B | −$771.5M | ||||||||
| Merck & Co IncCOM · shares +0.9% · price +21.0% | 2.0% | $11.39B | +$1.96B | ||||||||
| NvidiaCOM · shares +22% · price +82.5% | 2.0% | $11.26B | +$4.17B | ||||||||
| AlphabetCAP STK CL A · shares −5.9% · price +8.0% | 2.0% | $11.04B | +$821.9M | ||||||||
| AppleCOM · shares −1.4% · price −10.9% | 1.8% | $10.26B | −$1.26B | ||||||||
| MetaCL A · shares −7.3% · price +37.2% | 1.5% | $8.63B | +$2.34B | ||||||||
| Eli LillyCOM · shares −6.5% · price +33.5% | 1.5% | $8.57B | +$2.15B | ||||||||
| Jpmorgan Chase & CoCOM · shares −1.6% · price +17.8% | 1.4% | $7.81B | +$1.18B | ||||||||
| Danaher CorporationCOM · shares −4.3% · price +7.9% | 1.2% | $6.67B | +$491.2M | ||||||||
| Procter And Gamble CoCOM · shares −2.8% · price +10.7% | 0.96% | $5.41B | +$523.8M | ||||||||
| MastercardCL A · shares −6.3% · price +12.9% | 0.91% | $5.12B | +$585.9M | ||||||||
| Tjx Cos Inc NewCOM · shares −4.2% · price +8.1% | 0.89% | $5.02B | +$376.7M | ||||||||
| American Express CoCOM · shares +23% · price +21.5% | 0.89% | $5.01B | +$720.5M | ||||||||
| Pfizer IncCOM · shares −26% · price −3.6% | 0.87% | $4.93B | −$184.8M | ||||||||
| Visa Inc.COM CL A · shares −1.9% · price +7.2% | 0.86% | $4.87B | +$326.6M | ||||||||
| Texas InstrumentsCOM · shares +1.1% · price +2.2% | 0.76% | $4.31B | +$91.9M | ||||||||
| Accenture Plc IrelandSHS CLASS A · shares +12% · price −1.2% | 0.73% | $4.14B | −$46.0M | ||||||||
| General Dynamics CorpCOM · shares −6.4% · price +8.8% | 0.72% | $4.08B | +$329.5M | ||||||||
| Morgan StanleyCOM NEW · shares +12% · price +1.0% | 0.72% | $4.04B | +$35.0M | ||||||||
| Home Depot IncCOM · shares −1.1% · price +10.7% | 0.69% | $3.89B | +$375.7M | ||||||||
| Stryker CorporationCOM · shares −11% · price +19.5% | 0.69% | $3.88B | +$633.0M | ||||||||
| Hca Healthcare IncCOM · shares +13% · price +23.2% | 0.68% | $3.84B | +$640.2M | ||||||||
| Johnson & JohnsonCOM · shares −1.1% · price +0.9% | 0.67% | $3.76B | +$34.4M | ||||||||
| Total · 1,887 positions | 100% | $564.44B | +$40.42B |
Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.
What made money
From Q4 2023 to Q1 2024: 1,585 stocks held throughout, up $40.42B (+8.4%).
- Nvidia+$4.17B+82%
- Microsoft+$2.63B+12%
- Meta+$2.34B+37%
- Amazon+$2.21B+19%
- Eli Lilly+$2.15B+33%
- Nike Inc−$282.3M−13%
- Alnylam Pharmaceuticals Inc−$302.5M−22%
- Humana Inc−$595.8M−24%
- Unitedhealth Group Inc−$771.5M−6%
- Apple−$1.26B−11%
Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out, 3 splits read into the share counts.
Reported value by quarter
The total value of each quarter's 13F at that quarter end. It moves with prices as well as with buying and selling. Pick a quarter to see what the fund held then.
Every quarter's filing
| Quarter | Reported value | Filing | |
|---|---|---|---|
| Q2 2026 | Aug 14, 2026 | $580.17B+8% | SEC ↗ |
| Q1 2026 | May 15, 2026 | $535.46B−6% | SEC ↗ |
| Q4 2025 | Feb 17, 2026 | $570.66B−0% | SEC ↗ |
| Q3 2025 | Nov 14, 2025 | $571.31B+4% | SEC ↗ |
| Q2 2025 | Aug 14, 2025 | $550.98B+6% | SEC ↗ |
| Q1 2025 | May 13, 2025 | $519.87B−5% | SEC ↗ |
| Q4 2024 | Feb 12, 2025 (amended) | $546.18B−4% | SEC ↗ |
| Q3 2024 | Nov 14, 2024 | $570.97B+2% | SEC ↗ |
| Q2 2024 | Aug 14, 2024 | $560.18B−1% | SEC ↗ |
| Q1 2024 | May 15, 2024 | $564.44B+5% | SEC ↗ |
| Q4 2023 | Feb 12, 2024 (amended) | $536.37B+7% | SEC ↗ |
| Q3 2023 | Nov 14, 2023 (amended) | $499.52B−5% | SEC ↗ |
| Q2 2023 | Aug 14, 2023 | $527.49B+5% | SEC ↗ |
| Q1 2023 | May 12, 2023 | $504.61B+1% | SEC ↗ |
| Q4 2022 | Feb 13, 2023 | $498.70B+6% | SEC ↗ |
| Q3 2022 | Nov 14, 2022 | $469.49B−5% | SEC ↗ |
| Q2 2022 | Aug 15, 2022 | $496.55B−15% | SEC ↗ |
| Q1 2022 | May 16, 2022 | $583.99B−7% | SEC ↗ |
| Q4 2021 | Feb 11, 2022 | $625.28B+6% | SEC ↗ |
| Q3 2021 | Nov 15, 2021 | $587.95B−2% | SEC ↗ |
| Q2 2021 | Aug 16, 2021 | $600.78B+6% | SEC ↗ |
| Q1 2021 | May 17, 2021 | $567.83B+5% | SEC ↗ |
| Q4 2020 | Feb 12, 2021 | $543.08B+12% | SEC ↗ |
| Q3 2020 | Nov 16, 2020 | $483.12B+8% | SEC ↗ |
| Q2 2020 | Aug 14, 2020 | $449.13B+19% | SEC ↗ |
| Q1 2020 | May 14, 2020 | $377.87B−21% | SEC ↗ |
| Q4 2019 | Feb 11, 2020 | $477.16B+8% | SEC ↗ |
| Q3 2019 | Nov 13, 2019 | $443.46B−2% | SEC ↗ |
| Q2 2019 | Aug 14, 2019 | $451.69B+2% | SEC ↗ |
| Q1 2019 | May 15, 2019 | $441.54B+11% | SEC ↗ |
| Q4 2018 | Feb 14, 2019 | $399.54B−16% | SEC ↗ |
| Q3 2018 | Nov 14, 2018 | $474.88B+6% | SEC ↗ |
| Q2 2018 | Aug 14, 2018 | $449.23B+2% | SEC ↗ |
| Q1 2018 | May 15, 2018 | $441.92B−2% | SEC ↗ |
| Q4 2017 | Feb 13, 2018 | $452.59B+4% | SEC ↗ |
| Q3 2017 | Nov 13, 2017 | $435.63B+3% | SEC ↗ |
| Q2 2017 | Aug 14, 2017 | $424.69B+2% | SEC ↗ |
| Q1 2017 | May 11, 2017 | $415.20B+4% | SEC ↗ |
| Q4 2016 | Feb 14, 2017 | $398.65B−0% | SEC ↗ |
| Q3 2016 | Nov 14, 2016 | $399.22B+3% | SEC ↗ |
| Q2 2016 | Aug 15, 2016 | $386.87B+2% | SEC ↗ |
| Q1 2016 | May 13, 2016 | $379.99B | SEC ↗ |